For individuals affected by end-stage Age-Related Macular Degeneration (AMD), The Retina of Group of Washington is happy to provide the CentraSight treatment program. With over twenty-six board-certified doctors on staff, you’ll be certain to find the right retina surgeon in Alexandria at our practice to perform this state-of-the-art procedure.
The CentraSight treatment features an FDA-approved tiny telescope which is implanted inside the eye to improve vision and quality of life. This implantable telescope technology reduces the impact of the blind spot in the patient’s central vision caused by AMD, improving distance and near-vision. This is possible by the telescope implant, about the size of a pea, projecting the objects the patient is attempting to see onto the healthy area of the retina that has not degenerated. The eye with the implant provides central vision, while the other eye provides the patient peripheral vision. To be considered a potential candidate for CentraSight, in most cases, your ophthalmologist and retina surgeon in Alexandria must confirm that you meet certain criteria. This includes having irreversible, end-stage AMD resulting from either the dry or wet form of the disease. The patient must also no longer be a candidate for drug treatment of AMD and has not had cataract surgery in the eye in which the telescope will be implanted. After one of our ophthalmologists has confirmed you are a candidate, your vision will be tested with an external telescope simulator. The results of this test, in addition to visual training/rehabilitation evaluation visits, will help us determine if you are likely to benefit from the CentraSight treatment program.
If you are afflicted by AMD and meet certain age, vision, and cornea health requirements, then the CentraSight treatment program may be right for you. Please call The Retina Group of Washington today to speak with one of our retina surgeons in Alexandria if you have any questions regarding the treatment program itself or regarding your specific needs and concerns.